Impairment of memory and attention in the elderly

Neuroscience and Behavioral Physiology

Volumn 37, Issue 3, 2007, Pages 203-208

  Yakhno, N N ^a   Zakharov, V V ^a   Lokshina, A B ^a  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

ACTOVEGIN; ALPHA 2 ADRENERGIC RECEPTOR; AMINO ACID DERIVATIVE; AMINOPHYLLINE; AMIRIDINE; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CARDIOVASCULAR AGENT; CEREBROLYSIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; CINNARIZINE; DOPAMINE RECEPTOR STIMULATING AGENT; FLUNARIZINE; GALANTAMINE; GINKGO BILOBA EXTRACT; GLYCINE; LEVODOPA; LITHIUM; MEMANTINE; NEUROLEPTIC AGENT; NICERGOLINE; NIMODIPINE; PENTOXIFYLLINE; PIRACETAM; PIRIBEDIL; PRONORAN; RIVASTIGMINE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINPOCETINE;

AGED; AGING; ANXIETY DISORDER; ARTICLE; ATTENTION DISTURBANCE; BRAIN DISEASE; CARDIOVASCULAR DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; GERONTOPSYCHIATRY; HUMAN; LOW DRUG DOSE; MEMORY DISORDER; MENTAL CAPACITY; MONOTHERAPY; NEUROPSYCHOLOGICAL TEST; ONSET AGE; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; RECEPTOR BLOCKING; RECOMMENDED DRUG DOSE; RISK ASSESSMENT; RISK FACTOR; SINGLE DRUG DOSE; SYMPTOM; WORLD HEALTH ORGANIZATION;

AGED; ATTENTION; COGNITION DISORDERS; GERIATRICS; HUMANS; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS;

EID: 33947383663     PISSN: 00970549     EISSN: 1573899X     Source Type: Journal    
DOI: 10.1007/s11055-007-0002-y     Document Type: Article

References (36)

1. I. V. Damulin, Dyscirculatory Encephalopathy in the Elderly and Aged [in Russian], Author's abstract of thesis for doctorate in medical sciences, Moscow (1997).
2. I. V. Damulin, Alzheimer's Disease and Vascular Dementia [in Russian], N. N. Yakhno (ed.), Moscow (2002).
3. I. V. Damulin, V. A. Parfenov, A. A. Skoromets, and N. N. Yakhno, "Circulatory impairments in the brain and spinal cord," in: Diseases of the Nervous System. Handbook for Doctors [in Russian], N. N. Yakhno and D. R. Shtul'man (eds.), Meditsina, Moscow (2003), Vol. 1, pp. 231-302.
4. V. V. Zakharov, Cognitive Impairments in Parkinson's Disease and Symptomatic Parkinsonism [in Russian], Author's abstract of thesis for doctorate in medical sciences, Moscow (2003).
5. V. V. Zakharov and N. N. Yakhno, Memory Impairments [in Russian], GéotarMed, Moscow (2003).
6. V. V. Zakharov, N. V. Yaroslavtseva, and N. N. Yakhno, "Cognitive impairments in Parkinson's disease," Nevrol. Zh., 8, No. 2, 11-16, (2003).
7. V. V. Zakharov and A. B. Lokshina, "Use of Pronoran (piribedil) in mild cognitive impairments in elderly patients with dyscirculatory encephalopathy," Nevrol. Zh., 2, 30-35 (2004).
8. A. B. Lokshina, Mild and Moderate Cognitive Impairments in Dyscirculatory Encephalopathy [in Russian], Author's abstract of thesis for doctorate in medical sciences, Moscow (2005).
9. N. B. Man'kovskii and A. Ya. Mints, Aging and the Nervous System [in Russian], Kiev (1972).
10. A. V. Obukhova, "Use of the selective D2/D2_receptor agonist Pronoran (piribedil) in the treatment of Parkinson's disease," Nevrol. Zh., 3, 38-40 (2002).
11. E. V. Shmidt, "Classification of vascular lesions of the brain and spinal cord," Zh. Nevropatol. Psikhiat., 85, No. 9, 192-203 (1985).
12. N. N. Yakhno and A. Yu. Lavrov, "Changes in the central nervous system in aging," in: Neurodegenerative Diseases and Aging (Handbook for Doctors) [in Russian], I. A. Zavalishin, N. N. Yakhno, and S. I. Gavrilova (eds.), Moscow (2001), p. 242-261.
13. N. N. Yakhno, V. V. Zakharov, and A. B. Lokshina, "Moderate cognitive dysfunction syndrome in dyscirculatory encephalopathy," Zh. Nevrol. Psikhiat., 105, No. 2, 13-17 (2005).
14. N. N. Yakhno, A. B. Lokshina, and V. V. Zakharov, "Mild and moderate cognitive impairments in dyscirculatory encephalopathy," Klin. Gerontol., 25, No. 11, 38-38 (2005).
15. L. Amaducci and L. Andrea, "The epidemiology of the dementia in Europe," in: New Concepts in Vascular Dementia, A. Culebras, J. Matias Cuiu, and G. Roman (tds.), Prous Science Publishers, Barcelona (1993), pp. 19-27.
16. L. Bäckman, N. Ginovart, R. Dixon, et al., "Age-related cognitive deficits mediated by changes in the striatal dopamine system," Amer. J. Psychiat., 157, 635-637 (2000).
17. G. Bartoli and E. Wichrowska, "Controlled clinical trial of piribedil in the treatment of cerebrovascular insufficiency," La. Clin. Ter., 78, No. 2, 141-151 (1976).
18. J. Bille, J. V. Bukiwsky, A. De Ferron, et al., "Decline cerebral et therapeutique: Une Étude clinique multicentrique de Trivastal 50 retard en Neuro-Geriatrie," Psych. Med., 18, 609-626 (1986).
19. J. O. Ciocon and J. F. Potter, "Age-related changes in human memory: Normal and abnormal," Norm. Abnorm. Geriat., 43, No. 10, 43-48 (1988).
20. A. DiCarlo, M. Baldereschi, L. Amaducci, et al., "Cognitive impairment without dementia in older people: Prevalence, vascular risk factors, impact on disability. The Italian Longitudinal Study on Aging," J. Amer. Geriat. Soc., 48, 775-782 (2000).
21. M. F. Folstein, S. E. Folstein, and P. R. McHugh, "Mini-Mental State: A practical guide for grading the mental state of patients for the clinician," J. Psych. Res., 12, 189-198 (1975).
22. J. Golomb, A. Kluger, P. Garrard, and S. Ferris, Clinician's Manual on Mild Cognitive Impairment, Science Press, London (2001).
23. J. E. Graham, K. Rockwood, E. L. Beattie, et al., "Prevalence and severity of cognitive impairment with and without dementia in an elderly population," Lancet, 349, 1793-1796 (1997).
24. L. A. Hershey and W. A. Olszewski, "Ischemic vascular dementia," in: Handbook of Demented Illnesses, J. C. Morris (ed.), Marcel Dekker, New York (1994), pp. 335-351.
25. G. J. Larrabee and T. H. Crook, "Estimated prevalence of age associated memory impairment derived from standardized tests of memory function," Int. Psychogeriat., 6, No. 1, 95-104 (1994).
26. R. Levy, "Aging-associated cognitive decline," Int. Psychogeriat., 6, 63-68 (1994).
27. S. Lovenstone and S. Gauthier, Management of Dementia, Martin Dunitz, London (2001).
28. D. Nagaraia and S. Jayashree, "Randomised study of the dopamine receptor agonist piribedil in the treatment of mild cognitive impairment," Amer. J. Psychiat., 158, No. 9, 1517-1519 (2001).
29. R. S. Petersen, G. E. Smith, S. C. Waring, et al., "Aging, memory and mild cognitive impairment," Int. Psychogeriat., 9, 37-43 (1997).
30. R. S. Petersen, G. E. Smith, S. C. Waring, et al., "Mild cognitive impairment: Clinical characterization and outcome," Arch. Neurol., 56, 303-308 (1999).
31. R. S. Petersen, "Current concepts in mild cognitive impairment," Arch. Neurol., 58, 1985-1992 (2001).
32. R. C. Petersen, J. C. Stevens, M. Ganguli, et al., "Practice parameter. Early detection of dementia: Mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology," Neurology, 56, 1133-1142 (2001).
33. K. Ritchie, S. Artero, and J. Touchon, "Classification criteria for mild cognitive impairment: A population-based validation study," Neurology, 56, 37-42 (2001).
34. W. E. Scholing, "Controlled trial of Trivastal retard 50 and comparison with Trivastal 20 in the treatment of clinical and mental signs of neurovascular disease," Sci. Med., 4, 4-8 (1977).
35. W. E. Scholing, "A double-blind study using psychometric tests Trivastal versus a reference compound," Temp. Med., p. 114 (1982).
36. N. Volkow, G. Wang, J. Fowler, et al., "Parallel loss of presynaptic and postsynaptic dopamine markers in normal aging," Ann. Neurol., 44, No. 1, 143-147 (1998).